Skeletal Muscle Physiology Clinical Trial
Official title:
Muscle Memory After Treatment With Anabolic Substance Clenbuterol and Resistance Training in Humans: Myonuclear Addition, Hypertrophy and Myocellular Reprogramming
The purpose of the project is investigate muscle memory and underlying mechanisms in humans following resistance training and use of the anabolic substance clenbuterol.
Status | Recruiting |
Enrollment | 60 |
Est. completion date | August 1, 2025 |
Est. primary completion date | December 1, 2024 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 40 Years |
Eligibility | Inclusion Criteria: - Healthy men and women - BMI of <26 and normal ECG and blood pressure Exclusion Criteria: - Smoking - Chronic disease, - Use of prescription medication - Pain due to current or previous musculoskeletal injury - Resistance training more than once per week in the 12 months leading up to the intervention - Current or previous use of prohibited anabolic substances |
Country | Name | City | State |
---|---|---|---|
Denmark | August Krogh Building | Copenhagen |
Lead Sponsor | Collaborator |
---|---|
Morten Hostrup, PhD |
Denmark,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Fiber cross-sectional area | Immunohistochemistry to determine fiber cross-sectional area | The change in fiber cross-sectional is assessed at baseline, 8, 24 and 32 weeks | |
Primary | Myonuclei | Immunohistochemistry to determine number of myonuclei | The change in myonuclei is assessed at baseline, 8, 24 and 32 weeks | |
Primary | Skeletal muscle proteome | Pathway enrichment analysis of the muscle proteome using mass-spectrometry based proteomics | The change in the muscle proteome is assessed at baseline, 8, 24 and 32 weeks | |
Secondary | Lean mass | Lean mass assessed by dual X-ray absorptiometry (DXA) | The change in lean mass is assessed at baseline, 8, 24 and 32 weeks | |
Secondary | Isometric muscle strength | Maximal voluntary isometric contraction of m. quadriceps | The change in maximal voluntary isometric contraction is assessed at baseline, 8, 24 and 32 weeks | |
Secondary | Dynamic muscle strength | 1-repetition maximum | The change in 1-repetition maximum is assessed at baseline, 8, 24 and 32 weeks | |
Secondary | Sprint performance | Work performed (W) during a sprint on a bicycle ergometer | The change in sprint performance is assessed at baseline, 8, 24 and 32 weeks | |
Secondary | Satellite cells | Immunohistochemistry to determine number of satellite cells | The change in satellite cells is assessed at baseline, 8, 24 and 32 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT06188767 -
Testosterone-induced Muscle Memory and Underlying Mechanisms
|
N/A | |
Completed |
NCT04136457 -
Proteome Remodelling
|
N/A |